Steffen Sandmann

941 total citations
26 papers, 789 citations indexed

About

Steffen Sandmann is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Steffen Sandmann has authored 26 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 4 papers in Genetics. Recurrent topics in Steffen Sandmann's work include Renin-Angiotensin System Studies (6 papers), Ion channel regulation and function (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Steffen Sandmann is often cited by papers focused on Renin-Angiotensin System Studies (6 papers), Ion channel regulation and function (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Steffen Sandmann collaborates with scholars based in Germany, Netherlands and Denmark. Steffen Sandmann's co-authors include Thomas Schwarz, Thomas Unger, Mark Jean Gnoth, Ulf Buetehorn, Uwe Muenster, Minghuan Yu, T Unger, Lee Shaw, Freerk Prenzel and Mat J.A.P. Daemen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Steffen Sandmann

26 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffen Sandmann Germany 16 392 245 136 102 82 26 789
Piamsook Angkeow United States 9 355 0.9× 373 1.5× 33 0.2× 66 0.6× 61 0.7× 12 995
Xianmin Meng China 16 288 0.7× 195 0.8× 42 0.3× 81 0.8× 42 0.5× 42 597
Gregory S. Friedrichs United States 18 463 1.2× 298 1.2× 31 0.2× 53 0.5× 33 0.4× 50 948
Rajnikant Patel United States 12 927 2.4× 219 0.9× 172 1.3× 75 0.7× 22 0.3× 14 1.2k
Ahmed Aburima United Kingdom 17 246 0.6× 265 1.1× 33 0.2× 41 0.4× 67 0.8× 31 901
Yi Ma China 13 252 0.6× 326 1.3× 39 0.3× 63 0.6× 57 0.7× 24 942
Alice K. Robison United States 13 210 0.5× 230 0.9× 33 0.2× 36 0.4× 29 0.4× 18 788
Maribel Mirabet Spain 19 231 0.6× 378 1.5× 24 0.2× 35 0.3× 82 1.0× 26 1.1k
Xiaoxu Zhou China 17 127 0.3× 424 1.7× 17 0.1× 55 0.5× 71 0.9× 46 992
M.A.A. Kratzer Germany 12 197 0.5× 164 0.7× 60 0.4× 45 0.4× 16 0.2× 31 673

Countries citing papers authored by Steffen Sandmann

Since Specialization
Citations

This map shows the geographic impact of Steffen Sandmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Sandmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Sandmann more than expected).

Fields of papers citing papers by Steffen Sandmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Sandmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Sandmann. The network helps show where Steffen Sandmann may publish in the future.

Co-authorship network of co-authors of Steffen Sandmann

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Sandmann. A scholar is included among the top collaborators of Steffen Sandmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Sandmann. Steffen Sandmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janssen, Wiebke, Thomas Schwarz, Wolfram Steinke, et al.. (2022). Pharmacokinetics and mass balance of vericiguat in rats and dogs and distribution in rats. Xenobiotica. 52(5). 453–462. 4 indexed citations
2.
Baumann, Andreas, et al.. (2019). Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction. European Journal of Pharmaceutical Sciences. 130. 11–20. 25 indexed citations
3.
Zurth, Christian, et al.. (2018). Blood-brain barrier penetration of [14C]darolutamide compared with [14C]enzalutamide in rats using whole body autoradiography.. Journal of Clinical Oncology. 36(6_suppl). 345–345. 40 indexed citations
4.
Hagemann, Urs B., Anette Sommer, Alexander Kristian, et al.. (2017). Abstract 5199: Preclinical activity of the FGFR2-targeted thorium-227 conjugate in preclinical models of colorectal, gastric and triple-negative breast cancer. Cancer Research. 77(13_Supplement). 5199–5199. 4 indexed citations
5.
Gnoth, Mark Jean, Ulf Buetehorn, Uwe Muenster, Thomas Schwarz, & Steffen Sandmann. (2011). In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban. Journal of Pharmacology and Experimental Therapeutics. 338(1). 372–380. 183 indexed citations
6.
Gnoth, Mark Jean, Steffen Sandmann, Katrin Engel, & Martin Radtke. (2010). In Vitro to In Vivo Comparison of the Substrate Characteristics of Sorafenib Tosylate toward P-Glycoprotein. Drug Metabolism and Disposition. 38(8). 1341–1346. 38 indexed citations
7.
Sandmann, Steffen, et al.. (2006). Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats. Blood Pressure. 15(2). 116–128. 25 indexed citations
8.
Sandmann, Steffen, et al.. (2005). Detection of Human Hantavirus Infections in Lithuania. Infection. 33(2). 66–72. 27 indexed citations
9.
Buetehorn, Ulf, C. Kohlsdorfer, U. Pleiß, et al.. (2005). Pharmacokinetics of BAY 59-7939 – an oral, direct Factor Xa inhibitor – in rats and dogs. Xenobiotica. 35(9). 891–910. 86 indexed citations
10.
Mauler, Frank, Ervin Horváth, Jean De Vry, et al.. (2003). BAY 38–7271: A Novel Highly Selective and Highly Potent Cannabinoid Receptor Agonist for the Treatment of Traumatic Brain Injury. CNS Drug Reviews. 9(4). 343–358. 27 indexed citations
11.
Sandmann, Steffen, Freerk Prenzel, Lee Shaw, Roland Schauer, & Thomas Unger. (2002). Activity profile of calpains I and II in chronically infarcted rat myocardium – influence of the calpain inhibitor CAL 9961. British Journal of Pharmacology. 135(8). 1951–1958. 48 indexed citations
12.
Sandmann, Steffen, et al.. (2002). Calcium channel blockade limits transcriptional, translational and functional up-regulation of the cardiac calpain system after myocardial infarction. European Journal of Pharmacology. 453(1). 99–109. 15 indexed citations
13.
Sandmann, Steffen, et al.. (2002). Bradykinin B1 and B2 receptors differentially regulate cardiac Na+–H+ exchanger, Na+–Ca2+ exchanger and Na+–HCO3− symporter. European Journal of Pharmacology. 458(1-2). 3–16. 6 indexed citations
14.
Sandmann, Steffen, Minghuan Yu, Elena Kaschina, et al.. (2001). Differential effects of angiotensin AT1and AT2receptors on the expression, translation and function of the Na+-H+exchanger and Na+-HCO3−symporter in the rat heart after myocardial infarction. Journal of the American College of Cardiology. 37(8). 2154–2165. 46 indexed citations
15.
Sandmann, Steffen, Minghuan Yu, & Thomas Unger. (2001). Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction – effects of AT1 and AT2 receptor antagonists and ACE inhibitor. British Journal of Pharmacology. 132(3). 767–777. 51 indexed citations
16.
Sandmann, Steffen, et al.. (2001). Calcium Channel Blockade Limits Cardiac Remodeling and Improves Cardiac Function in Myocardial Infarction-Induced Heart Failure in Rats. Journal of Cardiovascular Pharmacology. 37(1). 64–77. 40 indexed citations
17.
Sandmann, Steffen, R. M. Bohle, Thomas Dreyer, & Thomas Unger. (2000). The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 436(2). 147–157. 24 indexed citations
18.
19.
Chung, Oliver, et al.. (1999). Effects of a novel angiotensin AT1 receptor antagonist, HR720, on rats with myocardial infarction. European Journal of Pharmacology. 385(2-3). 171–179. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piamsook Angkeow Breakdown of academic impact, for papers by Xianmin Meng Breakdown of academic impact, for papers by Gregory S. Friedrichs Breakdown of academic impact, for papers by Rajnikant Patel Breakdown of academic impact, for papers by Ahmed Aburima Breakdown of academic impact, for papers by Yi Ma Breakdown of academic impact, for papers by Alice K. Robison Breakdown of academic impact, for papers by Maribel Mirabet Breakdown of academic impact, for papers by Xiaoxu Zhou Breakdown of academic impact, for papers by M.A.A. Kratzer
Rankless by CCL
2026